JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2003; 41:893-904, doi:10.1016/S0735-1097(02)02965-0
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rahimtoola, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rahimtoola, S. H.

STATE-OF-THE-ART PAPER

Choice of prosthetic heart valve for adult patients

Shahbudin H. Rahimtoola, MB, FRCP, MACP, MACC, DSc(Hon)*,*

* Griffith Center, Division of Cardiovascular Medicine, Department of Medicine, LAC + USC Medical Center, Keck School of Medicine at the University of Southern California, Los Angeles, California, USA

Manuscript received April 23, 2002; revised manuscript received October 11, 2002, accepted October 17, 2002.

* Reprint requests and correspondence: Dr. Shahbudin H. Rahimtoola, University of Southern California, 2025 Zonal Avenue, Los Angeles, California, USA 90033.

This review summarizes the major long-term (≥10 to 15 years) patient outcomes after insertion of many Food and Drug Administration approved prosthetic heart valves (PHV). Mechanical PHV was associated with a better survival (p < 0.02) at 15 years after aortic valve replacement (AVR) than with a bioprosthesis in the Department of Veterans Affairs (DVA) trial. In both the DVA and the Edinburgh Heart Valve trials, bioprosthesis were associated with structural valve deterioration (SVD) (mitral valve replacement [MVR] > AVR) and, therefore, for replacement of the PHV. Thromboembolism and bleeding rate were higher with mechanical PHV. Mortality after AVR and MVR is high at 10 to 15 years because of the associated comorbid conditions and older age of patients. Outcomes with "new" good valves are similar to that with "older" good valves. Complication rates of thromboembolism, bleeding, endocarditis, and leak vary widely; the rates of these complications are not different among different mechanical PHV and among different bioprosthetic PHV. Structural valve deterioration is rare with mechanical PHV. Structural valve deterioration of bioprosthesis after MVR is higher than after AVR; after AVR, homografts and bioprosthesis have similar rates of SVD. The exact rate of SVD of the pulmonary autograft is uncertain. Valve prosthesis-patient mismatch is clinically important when it is severe and in selected patients when it is moderate. Bioprosthesis have a low rate of SVD in the older patient and, thus, are the PHV of choice for AVR in patients ≥60 to 65 years of age and for MVR in patients ≥65 to 70 years of age; in younger patients mechanical valves are the PHV of choice. In individual patients there may be exceptions to these general rules.

Abbreviations and Acronyms
  AVR
  aortic valve replacement
  CABG
  coronary artery bypass graft surgery
  CAD
  coronary artery disease
  DVA
  Department of Veterans Affairs
  FDA
  Food and Drug Administration
  INR
  international normalized ratio
  NYHA
  New York Heart Association
  LVEF
  left ventricular ejection fraction
  MO
  modified orifice
  MVR
  mitral valve replacement
  OPC
  optimal performance characteristics
  PHV
  prosthetic heart valve
  SVD
  structural valve deterioration
  VP-PM
  valve prosthesis-patient mismatch




This article has been cited by other articles:


Home page
CirculationHome page
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Circulation, October 7, 2008; 118(15): e523 - e661.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142.
[Full Text] [PDF]


Home page
HeartHome page
E B Schelbert, M S Vaughan-Sarrazin, K F Welke, and G E Rosenthal
Valve type and long-term outcomes after aortic valve replacement in older patients
Heart, September 1, 2008; 94(9): 1181 - 1188.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
T. Guenther, C. Noebauer, D. Mazzitelli, R. Busch, P. Tassani-Prell, and R. Lange
Tricuspid valve surgery: a thirty-year assessment of early and late outcome
Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 402 - 409.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. A.C. Ennker, A. A. Albert, U. P. Rosendahl, I. C. Ennker, F. Dalladaku, and I. Florath
Ten-Year Experience With Stentless Aortic Valves: Full-Root Versus Subcoronary Implantation
Ann. Thorac. Surg., February 1, 2008; 85(2): 445 - 453.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. El Oakley, P. Kleine, and D. S. Bach
Choice of Prosthetic Heart Valve in Today's Practice
Circulation, January 15, 2008; 117(2): 253 - 256.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. Hickey, S. M. Langley, O. Allemby-Smith, S. A. Livesey, and J. L. Monro
Subcoronary Allograft Aortic Valve Replacement: Parametric Risk-Hazard Outcome Analysis to a Minimum of 20 Years
Ann. Thorac. Surg., November 1, 2007; 84(5): 1564 - 1570.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. L. Svennevig, M. Abdelnoor, and S. Nitter-Hauge
Twenty-Five Year Experience With the Medtronic-Hall Valve Prosthesis in the Aortic Position: A Follow-Up Cohort Study of 816 Consecutive Patients
Circulation, October 16, 2007; 116(16): 1795 - 1800.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
K. Prasongsukarn, W. E. Jamieson, E. Germann, F. Chan, and S. V Lichtenstein
Aortic and Mitral Prosthetic Valve Replacement in Age Groups 61 65 & 66 70 Years
Asian Cardiovasc Thorac Ann, April 1, 2007; 15(2): 127 - 133.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, A. Vahanian, H. Baumgartner, J. Bax, E. Butchart, R. Dion, G. Filippatos, F. Flachskampf, R. Hall, B. Iung, et al.
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology
Eur. Heart J., January 26, 2007; (2007) ehl428v1.
[Full Text] [PDF]


Home page
J Intensive Care MedHome page
K. K. Stout and C. M. Otto
Indications for Aortic Valve Replacement in Aortic Stenosis
J Intensive Care Med, January 1, 2007; 22(1): 14 - 25.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Kunihara, K. Schmidt, P. Glombitza, V. Dzindzibadze, H. Lausberg, and H.-J. Schafers
Root replacement using stentless valves in the small aortic root: a propensity score analysis.
Ann. Thorac. Surg., October 1, 2006; 82(4): 1379 - 1384.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
G. Van Nooten, P. Somers, M. Cornelissen, S. Bouchez, F. Gasthuys, E. Cox, L. Sparks, and K. Narine
Acellular porcine and kangaroo aortic valve scaffolds show more intense immune-mediated calcification than cross-linked Toronto SPV(R) valves in the sheep model
Interactive CardioVascular and Thoracic Surgery, October 1, 2006; 5(5): 544 - 549.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. O. Bohm, C. A. Botha, A. Horke, W. Hemmer, D. Roser, G. Blumenstock, F. Uhlemann, and J.-G. Rein
Is the Ross operation still an acceptable option in children and adolescents?
Ann. Thorac. Surg., September 1, 2006; 82(3): 940 - 947.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol., August 1, 2006; 48(3): 598 - 675.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. H. Rahimtoola
Is severe valve prosthesis-patient mismatch (VP-PM) associated with a higher mortality?
Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 1 - 1.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. S. Gammie, J. W. Brown, J. M. Brown, R. S. Poston, R. N. Pierson III, P. N. Odonkor, C. S. White, J. S. Gottdiener, and B. P. Griffith
Aortic valve bypass for the high-risk patient with aortic stenosis.
Ann. Thorac. Surg., May 1, 2006; 81(5): 1605 - 1610.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. R. Moon, M. K. Pasque, N. A. Munfakh, S. J. Melby, J. S. Lawton, N. Moazami, J. E. Codd, T. D. Crabtree, H. B. Barner, and R. J. Damiano Jr
Prosthesis-Patient Mismatch After Aortic Valve Replacement: Impact of Age and Body Size on Late Survival
Ann. Thorac. Surg., February 1, 2006; 81(2): 481 - 489.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Roscitano, U. Benedetto, A. Sciangula, E. Merico, F. Barberi, R. Bianchini, E. Tonelli, and R. Sinatra
Indexed effective orifice area after mechanical aortic valve replacement does not affect left ventricular mass regression in elderly
Eur. J. Cardiothorac. Surg., February 1, 2006; 29(2): 139 - 143.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. H. Rahimtoola
The Year in Valvular Heart Disease
J. Am. Coll. Cardiol., January 17, 2006; 47(2): 427 - 439.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Doss, J. P. Wood, S. Martens, G. Wimmer-Greinecker, and A. Moritz
Do Pulmonary Autografts Provide Better Outcomes Than Mechanical Valves? A Prospective Randomized Trial
Ann. Thorac. Surg., December 1, 2005; 80(6): 2194 - 2198.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
I. Vesely
Heart Valve Tissue Engineering
Circ. Res., October 14, 2005; 97(8): 743 - 755.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. B. Schelbert, G. E. Rosenthal, K. F. Welke, and M. S. Vaughan-Sarrazin
Treatment Variation in Older Black and White Patients Undergoing Aortic Valve Replacement
Circulation, October 11, 2005; 112(15): 2347 - 2353.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
U. Elkayam and F. Bitar
Valvular Heart Disease and Pregnancy: Part II: Prosthetic Valves
J. Am. Coll. Cardiol., August 2, 2005; 46(3): 403 - 410.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. E. Ruiz, M. Iemura, S. Medie, P. Varga, W. G. Van Alstine, S. Mack, A. Deligio, N. Fearnot, U. H. Beier, D. Pavcnik, et al.
Transcatheter placement of a low-profile biodegradable pulmonary valve made of small intestinal submucosa: A long-term study in a swine model
J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 477 - 484.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. B. Schelbert, M. S. Vaughan-Sarrazin, K. F. Welke, and G. E. Rosenthal
Hospital Volume and Selection of Valve Type in Older Patients Undergoing Aortic Valve Replacement Surgery in the United States
Circulation, May 3, 2005; 111(17): 2178 - 2182.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Weber, R. Arnold, M. Rau, A. Elsaesser, R. Brandt, V. Mitrovic, and C. Hamm
Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease
Eur. Heart J., May 2, 2005; 26(10): 1023 - 1030.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Bonow, M. D. Cheitlin, M. H. Crawford, and P. S. Douglas
Task Force 3: Valvular heart disease
J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1334 - 1340.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. H. Rahimtoola
The year in valvular heart disease
J. Am. Coll. Cardiol., January 4, 2005; 45(1): 111 - 122.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. M. Connolly, I. Alferiev, J. N. Clark-Gruel, N. Eidelman, M. Sacks, E. Palmatory, A. Kronsteiner, S. DeFelice, J. Xu, R. Ohri, et al.
Triglycidylamine Crosslinking of Porcine Aortic Valve Cusps or Bovine Pericardium Results in Improved Biocompatibility, Biomechanics, and Calcification Resistance: Chemical and Biological Mechanisms
Am. J. Pathol., January 1, 2005; 166(1): 1 - 13.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
H. Machler, M. Perthel, G. Reiter, U. Reiter, M. Zink, P. Bergmann, A. Waltensdorfer, and J. Laas
Influence of bileaflet prosthetic mitral valve orientation on left ventricular flow--an experimental in vivo magnetic resonance imaging study
Eur. J. Cardiothorac. Surg., October 1, 2004; 26(4): 747 - 753.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Rahimtoola
Reply
J. Am. Coll. Cardiol., August 4, 2004; 44(3): 667 - 668.
[Full Text] [PDF]


Home page
CirculationHome page
J. Bergler-Klein, U. Klaar, M. Heger, R. Rosenhek, G. Mundigler, H. Gabriel, T. Binder, R. Pacher, G. Maurer, and H. Baumgartner
Natriuretic Peptides Predict Symptom-Free Survival and Postoperative Outcome in Severe Aortic Stenosis
Circulation, May 18, 2004; 109(19): 2302 - 2308.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Ruel, A. Kulik, F. D. Rubens, P. Bedard, R. G. Masters, A. L. Pipe, and T. G. Mesana
Late incidence and determinants of reoperation in patients with prosthetic heart valves
Eur. J. Cardiothorac. Surg., March 1, 2004; 25(3): 364 - 370.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. H. Rahimtoola
The year in valvular heart disease
J. Am. Coll. Cardiol., February 4, 2004; 43(3): 491 - 504.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. S. Bach
Choice of prosthetic heart valves:update for the next generation
J. Am. Coll. Cardiol., November 19, 2003; 42(10): 1717 - 1719.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. H. Rahimtoola
The next generation of prosthetic heart valves needs a proven track record of patient outcomes at >=15 to 20 years
J. Am. Coll. Cardiol., November 19, 2003; 42(10): 1720 - 1721.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2003 by the American College of Cardiology Foundation.